We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVH icon
351
Invitation Homes
INVH
$18B
$240K 0.1%
+7,331
New +$246K
TPC
352
Tutor Perini Cor
TPC
$5.21B
$239K 0.1%
+5,103
New +$162K
PAHC icon
353
Phibro Animal Health
PAHC
$1.39B
$236K 0.1%
+9,240
New +$201K
NGVC icon
354
Vitamin Cottage Natural Grocers
NGVC
$654M
$236K 0.1%
+6,010
New +$278K
RGNX icon
355
Regenxbio
RGNX
$708M
$235K 0.1%
28,639
+4,234
+17% +$35.4K
NOG icon
356
Northern Oil and Gas
NOG
$2.35B
$233K 0.1%
+8,232
New +$221K
LZ icon
357
LegalZoom.com
LZ
$988M
$231K 0.1%
+25,981
New +$218K
STAG icon
358
STAG Industrial
STAG
$7.19B
$231K 0.1%
+6,380
New +$221K
HURN icon
359
Huron Consulting
HURN
$2.42B
$231K 0.1%
1,679
-2,000
-54% -$284K
RTX icon
360
RTX Corp
RTX
$301B
$231K 0.1%
+1,581
New +$211K
URGN icon
361
UroGen Pharma
URGN
$2.29B
$229K 0.1%
+16,747
New +$161K
NVT icon
362
nVent Electric
NVT
$26.7B
$229K 0.1%
3,121
-4,180
-57% -$257K
LZB icon
363
La-Z-Boy
LZB
$1.69B
$227K 0.1%
+6,114
New +$244K
SPSC icon
364
SPS Commerce
SPSC
$2.64B
$227K 0.1%
+1,669
New +$231K
AVNS
365
DELISTED
Avanos Medical
AVNS
$227K 0.1%
18,512
+568
+3% +$7.14K
SO icon
366
Southern Company
SO
$107B
$227K 0.1%
2,467
-7,363
-75% -$661K
AVAH icon
367
Aveanna Healthcare
AVAH
$2.07B
$226K 0.1%
43,302
+18,626
+75% +$94.7K
AAOI icon
368
Applied Optoelectronics
AAOI
$11.5B
$224K 0.1%
+8,720
New +$141K
AGO icon
369
Assured Guaranty
AGO
$3.34B
$224K 0.1%
+2,569
New +$219K
HLNE icon
370
Hamilton Lane
HLNE
$5.57B
$223K 0.1%
+1,569
New +$237K
WBA
371
DELISTED
Walgreens Boots Alliance
WBA
$220K 0.1%
+19,177
New +$214K
HLIT icon
372
Harmonic Inc
HLIT
$1.28B
$219K 0.1%
23,177
+10,595
+84% +$96.7K
AI icon
373
C3.ai
AI
$1.59B
$219K 0.09%
+8,895
New +$203K
OLO
374
DELISTED
Olo Inc
OLO
$218K 0.09%
24,523
+4,208
+21% +$32.6K
WAY
375
Waystar Holding Corp
WAY
$4.65B
$218K 0.09%
+5,335
New +$206K
13 14
15
16 17

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.